These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 17087427)

  • 1. Preventing cardiovascular disease in women.
    Hayes SN
    Am Fam Physician; 2006 Oct; 74(8):1331-40. PubMed ID: 17087427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National study of physician awareness and adherence to cardiovascular disease prevention guidelines.
    Mosca L; Linfante AH; Benjamin EJ; Berra K; Hayes SN; Walsh BW; Fabunmi RP; Kwan J; Mills T; Simpson SL
    Circulation; 2005 Feb; 111(4):499-510. PubMed ID: 15687140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Waist circumference predicts cardiometabolic and global Framingham risk among women screened during National Woman's Heart Day.
    Mosca L; Edelman D; Mochari H; Christian AH; Paultre F; Pollin I
    J Womens Health (Larchmt); 2006; 15(1):24-34. PubMed ID: 16417415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge and risk of cardiovascular disease in rural Alabama women.
    Hamner J; Wilder B
    J Am Acad Nurse Pract; 2008 Jun; 20(6):333-8. PubMed ID: 18588661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are at-risk New Zealand women receiving recommended cardiovascular preventive therapy?
    Bupha-Intr O; Rose SB; Lawton BA; Elley CR; Dowell AC
    N Z Med J; 2010 Feb; 123(1309):26-36. PubMed ID: 20186240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA; Wells S; Scragg RK; Jackson R
    N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SaM (Screening and Monitoring) approach to cardiovascular risk-reduction in primary care--cyclic monitoring and individual treatment of patients at cardiovascular risk using the electronic medical record.
    Rabinowitz I; Tamir A
    Eur J Cardiovasc Prev Rehabil; 2005 Feb; 12(1):56-62. PubMed ID: 15703507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Undertreatment and overtreatment with statins: the Oslo Health Study 2000-2001.
    Tonstad S; Rosvold EO; Furu K; Skurtveit S
    J Intern Med; 2004 Apr; 255(4):494-502. PubMed ID: 15049884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Guideline 'Cardiovascular Risk Management'].
    Burgers JS; Simoons ML; Hoes AW; Stehouwer CD; Stalman WA
    Ned Tijdschr Geneeskd; 2007 May; 151(19):1068-74. PubMed ID: 17552415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease prevention tailored for women.
    Engberding N; Wenger NK
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1123-34. PubMed ID: 18793115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular disease in Chinese women: an emerging high-risk population and implications for nursing practice.
    Cao Y; DiGiacomo M; Du HY; Ollerton E; Davidson P
    J Cardiovasc Nurs; 2008; 23(5):386-94; quiz 395-6. PubMed ID: 18728510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global preventive policies. Strategies at European and worldwide level.
    Kotseva K
    Rev Esp Cardiol; 2008 Sep; 61(9):960-70. PubMed ID: 18775238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to the AICR cancer prevention recommendations and subsequent morbidity and mortality in the Iowa Women's Health Study cohort.
    Cerhan JR; Potter JD; Gilmore JM; Janney CA; Kushi LH; Lazovich D; Anderson KE; Sellers TA; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1114-20. PubMed ID: 15247121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormones and cardiovascular health in women.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin use in the prevention of cardiovascular events.
    Crutcher JM; Mallonee S; Daniels C
    J Okla State Med Assoc; 2007 Oct; 100(10):383-7. PubMed ID: 18085095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National study of women's awareness, preventive action, and barriers to cardiovascular health.
    Mosca L; Mochari H; Christian A; Berra K; Taubert K; Mills T; Burdick KA; Simpson SL
    Circulation; 2006 Jan; 113(4):525-34. PubMed ID: 16449732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of walking in preventing cardiovascular disease in women: a review of the current literature.
    Albright C; Thompson DL
    J Womens Health (Larchmt); 2006 Apr; 15(3):271-80. PubMed ID: 16620186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of primary versus secondary cardiovascular disease prevention in an academic family practice.
    Eaton CB; McQuade W; Glupczynski D
    Fam Med; 1994 Oct; 26(9):587-92. PubMed ID: 7843510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges for the management of hypertension in low-resource settings.
    Mendis S
    Ethn Dis; 2003; 13(2 Suppl 2):S67-70. PubMed ID: 13677416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The first SHAPE (Screening for Heart Attack Prevention and Education) guideline.
    Naghavi M; Falk E; Hecht HS; Shah PK;
    Crit Pathw Cardiol; 2006 Dec; 5(4):187-90. PubMed ID: 18340236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.